Sophie Schaller - Concepedia

Author

Sophie Schaller

Nordic Bioscience (Denmark)

Also Known As

S Schaller, S. Schaller, Samantha Schaller, Sophie A Schaller, Sophie Schaller

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Nordic Bioscience (Denmark)Oslo University Hospital Center for Clinical & Basic Research Inserm Hospital South West Jutland

About

Sophie Schaller is an author at Nordic Bioscience (Denmark) specializing in medicine, orthopaedics, and osteoporosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	604
2	Cell Biology	3	3	257
3	Engineering	1	1	154
4	Cellular Physiology	1	1	27
5	Immunology	1	1	142

Sophie Schaller

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Mechanism of mitochondrial permeability transition pore induction and damage in the pancreas: inhibition prevents acute pancreatitis by protecting production of ATP Rajarshi Mukherjee, Olga A. Mareninova, Irina Odinokova, Gut	2015	219
Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results Dan Atar, Håkan Arheden, Alain Berdeaux, European Heart Journal	2014	183
Acidification of the Osteoclastic Resorption Compartment Provides Insight into the Coupling of Bone Formation to Bone Resorption M.A. Karsdal, Kim Henriksen, Mette G Sørensen, American Journal Of Pathology MechanobiologyEngineeringBone ResorptionBiomechanicsBone Remodeling	2005	154
The Chloride Channel Inhibitor NS3736 Prevents Bone Resorption in Ovariectomized Rats Without Changing Bone Formation Sophie Schaller, Kim Henriksen, Christina Sveigaard, Journal of Bone and Mineral Research	2004	146
Characterization of osteoclasts derived from CD14+ monocytes isolated from peripheral blood Mette G Sørensen, Kim Henriksen, Sophie Schaller, Journal of Bone and Mineral Metabolism Bone Morphogenic ProteinImmunologyPeripheral BloodBone HomeostasisCd14+ Monocytes	2006	142
Characterization of Osteoclasts from Patients Harboring a G215R Mutation in ClC-7 Causing Autosomal Dominant Osteopetrosis Type II Kim Henriksen, Jeppe Gram, Sophie Schaller, American Journal Of Pathology Bone DiseaseSclerostinBone Morphogenic ProteinGeneticsPathology	2004	123
TRO40303, a New Cardioprotective Compound, Inhibits Mitochondrial Permeability Transition Sophie Schaller, Stéphanie Paradis, Gladys A. Ngoh, Journal of Pharmacology and Experimental Therapeutics	2010	114
Degradation of the Organic Phase of Bone by Osteoclasts: A Secondary Role for Lysosomal Acidification Kim Henriksen, Mette G Sørensen, Rasmus Hjorth Nielsen, Journal of Bone and Mineral Research	2006	95
Calcitonin directly attenuates collagen type II degradation by inhibition of matrix metalloproteinase expression and activity in articular chondrocytes B.C. Søndergaard, Helle Wulf, Kim Henriksen, Osteoarthritis and Cartilage Tissue EngineeringFibrosisArticular ChondrocytesBone Morphogenic ProteinMatrix Metalloproteinase Expression	2006	88
Osteoclasts from Patients with Autosomal Dominant Osteopetrosis Type I Caused by a T253I Mutation in Low-Density Lipoprotein Receptor-Related Protein 5 Are Normal in Vitro, but Have Decreased Resorption Capacity in Vivo Kim Henriksen, Jeppe Gram, Pernille Høegh-Andersen, American Journal Of Pathology Bone DiseaseT253i MutationAre NormalSclerostinBone Morphogenic Protein	2005	42

Page 1